Improved Survival and Cure Rates With Concurrent Treatment for Multidrug-Resistant Tuberculosis–Human Immunodeficiency Virus Coinfection in South Africa | Zendy

James C. M. Brust | Zendy; Neha Shah | Zendy; Koleka Mlisana | Zendy; Pravi Moodley | Zendy; Salim Allana | Zendy; Angela Campbell | Zendy; Brent A. Johnson | Zendy; Iqbal Master | Zendy; Thuli Mthiyane | Zendy; Simlatha Lachman | Zendy; Lee-Megan Larkan | Zendy; Yuming Ning | Zendy; Amyn A. Malik | Zendy; Jonathan P. Smith | Zendy; Neel R. Gandhi | Zendy

Open Access

Improved Survival and Cure Rates With Concurrent Treatment for Multidrug-Resistant Tuberculosis–Human Immunodeficiency Virus Coinfection in South Africa

Author(s) -

James C. M. Brust,

Neha Shah,

Koleka Mlisana,

Pravi Moodley,

Salim Allana,

Angela Campbell,

Brent A. Johnson,

Iqbal Master,

Thuli Mthiyane,

Simlatha Lachman,

Lee-Megan Larkan,

Yuming Ning,

Amyn A. Malik,

Jonathan P. Smith,

Neel R. Gandhi

Publication year - 2017

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/cix1125

Subject(s) - coinfection , tuberculosis , human immunodeficiency virus (hiv) , multiple drug resistance , medicine , virology , aids related opportunistic infections , antiretroviral therapy , immunology , sida , drug resistance , viral disease , viral load , biology , microbiology and biotechnology , pathology

Mortality in multidrug-resistant (MDR) tuberculosis-human immunodeficiency virus (HIV) coinfection has historically been high, but most studies predated the availability of antiretroviral therapy (ART). We prospectively compared survival and treatment outcomes in MDR tuberculosis-HIV-coinfected patients on ART to those in patients with MDR tuberculosis alone.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research